Section: Pet Parasites

Toxoplasmosis in Cats: Zoonotic Risk and Management in Households with Infants

Introduction

Toxoplasmosis is a globally distributed zoonotic disease caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii [1]. Felids, both domestic and wild, are the definitive hosts and the only species capable of excreting environmentally resistant oocysts in feces [1, 2]. The presence of a cat in a household, particularly one with infants, raises legitimate concerns regarding zoonotic transmission. While the parasite can infect virtually all warm-blooded animals, the cat serves as the primary epidemiologic link between environmental contamination and human infection [2, 3]. This review provides a veterinary-focused examination of T. gondii infection in cats, emphasizing the biologic mechanisms of transmission, clinical disease, diagnostic approaches, therapeutic strategies, and practical management protocols for households with infants. The topic of cat toxoplasmosis baby risk is addressed through an evidence-based lens, drawing on peer-reviewed literature from the past several decades.

Etiology and Life Cycle

Toxoplasma gondii exists in three infectious stages: tachyzoites (rapidly dividing), bradyzoites (slowly dividing within tissue cysts), and sporozoites (within oocysts) [1, 4]. The sexual cycle occurs exclusively in the feline intestinal epithelium, where ingestion of tissue cysts (typically from infected prey or raw meat) leads to entero-epithelial development and eventual oocyst shedding [4, 5]. Oocysts are shed unsporulated and become infective after sporulation, which requires 1 to 5 days depending on environmental conditions [1]. A single cat can excrete millions of oocysts, and oocyst shedding typically lasts 1 to 2 weeks but can be prolonged in some cases [1, 2]. The prepatent period after ingestion of tissue cysts is 3 to 10 days, while ingestion of oocysts results in a longer prepatent period (18 days or more) [4, 6]. Cats usually shed oocysts only once in their lifetime, although re-shedding can occur under immunosuppression or experimental reinfection [7, 8].

The bradyzoite stage within tissue cysts is the primary source of infection for cats [4]. Upon ingestion, the cyst wall is digested, releasing bradyzoites that invade enterocytes and initiate the sexual cycle [1, 9]. After the initial shedding period, cats develop humoral and cell-mediated immunity that limits further oocyst excretion but does not eliminate latent tissue cysts [6, 7]. These tissue cysts can persist for years, potentially reactivating under immunosuppression [10, 9].

Epidemiology of Toxoplasma gondii in Cats

Seroprevalence of T. gondii in domestic cats varies widely by geographic region, lifestyle, and management practices. In the United States, seroprevalence is estimated at approximately 30% [1, 5]. Brazilian studies report frequencies of 15.2% by ELISA and 7.6% by indirect immunofluorescence in Espírito Santo State [2], while in northeastern Brazil, a study found an overall seroprevalence of 38.67% [11]. In Pakistan, stray cats showed a markedly higher infection rate (74.6%) compared to pet cats (25.4%) [12]. A study in Greece reported 20.8% seropositivity among 457 cats using IFAT [13]. In Thailand, the overall prevalence was 6.5%, with semi-domesticated cats having 11.5% versus 1.5% in pet cats [14]. These data underscore the role of outdoor access, hunting behavior, and raw meat feeding as risk factors [13, 15].

Age is consistently identified as a risk factor, with older cats more likely to be seropositive due to cumulative exposure [7, 12, 13]. Male cats may have a higher prevalence in some populations, although results are not consistent across studies [12, 13]. Stray and feral cats constitute a major reservoir, as they have higher exposure rates and are more likely to shed oocysts in the environment [16, 17]. In Izmir, Turkey, T. gondii DNA was detected in 14.37% of stray cat feces samples, with a seroprevalence of 37.84% [16].

The role of cats as sentinel species for human toxoplasmosis has been proposed, as feline seroprevalence often correlates with environmental oocyst burden and human infection risk [18].

Clinical Signs and Pathology in Cats

Most cats infected with T. gondii remain asymptomatic [1, 9]. Clinical toxoplasmosis occurs more frequently in young kittens, immunosuppressed cats, or those co-infected with feline immunodeficiency virus (FIV) or feline leukemia virus (FeLV) [3, 9]. In a histopathologic review of 100 cats with confirmed toxoplasmosis, the median age was 2 years, and 65% were male [10]. The most common clinical signs included fever (73%), dyspnea, polypnea, and abdominal discomfort [10]. Neurologic signs, including ataxia, seizures, and behavioral changes, were observed in 7% of these cases [10].

Ocular toxoplasmosis is a frequent manifestation, with evidence of intraocular inflammation in 81.5% of affected cats in one series [10]. Multifocal iridocyclochoroiditis is the most common lesion, often involving the ciliary body, iris, and retina [10, 19]. Neurologic and ocular forms are well documented and can present as panuveitis, retinal detachment, or optic neuritis [20, 9].

Congenital toxoplasmosis in kittens is uncommon but can result in stillbirth, neonatal death, or severe neurologic deficits [21, 9]. In a study of neonatally induced toxoplasmosis, lesions were predominantly in the central nervous system and eyes [21]. Fatal acute toxoplasmosis has been reported in kittens as young as 8 weeks, often associated with feeding of raw meat and infection with specific genotypes such as ToxoDB #4 [5].

Postmortem findings in clinical toxoplasmosis include multifocal necrosis in the lungs, liver, spleen, and lymph nodes [10]. T. gondii organisms are most frequently identified in the brain (80%), lung (76.7%), and liver (70%) [10].

Zoonotic Risk to Infants and Household Management

The risk of toxoplasmosis transmission from cats to human infants is primarily via ingestion of sporulated oocysts [1, 2]. Infants are particularly vulnerable because of their immature immune systems and the potential for severe congenital or postnatal infection acquired from environmental contamination [22]. Direct transmission from petting or handling a cat is highly unlikely because cats do not carry oocysts on their fur unless fecally contaminated [1, 23]. The major risk factor for cat toxoplasmosis baby exposure is the presence of oocysts in the home environment, typically from a cat that is actively shedding [14, 16].

Because oocysts require 1 to 5 days to sporulate and become infectious, daily removal of cat feces from litter boxes is the single most effective preventive measure [1, 23]. Litter boxes should be cleaned by an adult wearing disposable gloves, and materials should be sealed in plastic bags before disposal [23, 16]. Infants should be kept away from litter boxes, sandboxes, and garden soil that may be contaminated with cat feces [23, 22]. Feeding cats only commercial cooked or canned food, and preventing hunting behavior, reduces the risk of the cat acquiring infection and subsequently shedding oocysts [1, 9, 23].

Households with infants should also ensure that cats are kept indoors to minimize exposure to infected prey [13, 15]. Pregnant women and immunocompromised individuals are also at risk, and standard precautions are well established [23, 22]. If a cat is known to be seropositive for T. gondii IgG, it has already shed oocysts (or is immune) and is unlikely to re-shed; however, acute infection with IgM positivity may indicate current or recent shedding, and the cat should be isolated during the shedding period [6, 12, 11]. Serologic testing of cats can be performed to assess exposure status, but a negative serology does not rule out future infection [6, 23].

Diagnostics

Antemortem diagnosis of feline toxoplasmosis relies on serology, molecular detection, and cytologic or histopathologic examination [9, 24]. The modified agglutination test (MAT) using formalin-preserved tachyzoites is highly sensitive and can detect antibodies as early as 2 to 3 weeks post-infection [6, 25]. Commercial ELISA kits for detection of anti-T. gondii IgG and IgM are widely used; the presence of IgM may indicate recent infection or reactivation [12, 11]. Western blotting is also employed for confirmation [15].

Polymerase chain reaction (PCR) targeting the B1 gene or 529-bp repeat element can detect T. gondii DNA in blood, feces, or tissue [12, 16, 15]. Real-time PCR is more sensitive and allows quantification [16]. In stray cats, PCR of feces yielded 14.37% positivity, while microscopy for oocysts was only 0.43% [16]. Serologic tests using recombinant antigens such as GRA7 and GRA3 have shown improved sensitivity and specificity compared to SAG2 [25].

Cytology of tracheal washes, bronchoalveolar lavage, or cerebrospinal fluid can reveal tachyzoites in clinically ill cats [10, 9]. Immunohistochemistry on biopsy or necropsy specimens confirms the presence of T. gondii antigen [10, 5].

Treatment and Control

Clindamycin at a dosage of 10 to 12 mg/kg orally every 12 hours for 4 weeks is the first-line treatment for clinical toxoplasmosis in cats [26, 9, 27]. In experimental acute toxoplasmosis, clindamycin showed efficacy in reducing clinical signs but did not eliminate tissue cysts [26]. Alternative therapies include ponazuril (toltrazuril sulfone) at 20 mg/kg once daily for 7 days and trimethoprim-sulfonamide combinations [9]. Clindamycin has also been used prophylactically in captive Pallas’ cats to reduce juvenile toxoplasmosis-associated mortality, achieving a 67% reduction in first-year mortality [27].

Supportive care includes fluid therapy, oxygen supplementation in cases of pneumonia, and nutritional support [9]. In cases of ocular toxoplasmosis, topical or systemic corticosteroids may be used cautiously alongside antiprotozoal therapy to control inflammation [19, 9].

Prevention of infection in cats is achieved by restricting outdoor access, eliminating raw meat from the diet, and controlling rodent populations [1, 23]. A live attenuated vaccine (RHΔompdcΔuprt) has shown promise in reducing oocyst shedding by 95.3% in experimentally vaccinated cats, though it is not yet commercially available [28]. Vaccination strategies that block oocyst shedding represent a future direction for zoonotic risk reduction [28, 29].

Decision Tree for Managing Toxoplasmosis Risk in Households with Infants

The following Mermaid diagram summarizes a clinical decision framework for veterinary practitioners advising households with infants.

flowchart TD
    A[Household with cat and infant], > B{Is the cat's infection status known?}
    B, >|Yes, serologically tested| C{IgG positive?}
    C, >|Yes| D[Cat has previously been infected and is likely immune. Low risk of current oocyst shedding. Advise standard hygiene.]
    C, >|No| E[Cat may be susceptible. Advise prevention: indoor confinement, no raw meat.]
    B, >|No| F[Perform serology?]
    F, >|Yes| G[ELISA or IFAT for IgG and IgM]
    G, >|IgM positive| H[Assume recent or active infection. Isolate cat from infant and litter box. Retest in 2 weeks.]
    G, >|IgG only| D
    G, >|Negative| E
    F, >|No| I[Implement universal precautions: daily litter box cleaning by non-pregnant adult, gloves, disinfection, keep infant away from litter.]
    H, > J[Re-test until IgG positive and IgM negative. Consider PCR on feces if shedding suspected.]
    J, >|PCR positive| K[Quarantine until shedding ceases (1-2 weeks). Treat if clinical signs present.]
    J, >|PCR negative| D

Conclusion

Toxoplasmosis in cats remains a significant zoonotic concern, particularly in households with infants where environmental oocyst contamination poses a risk for severe neonatal infection [1, 22]. Cats acquire T. gondii through ingestion of tissue cysts, and only a brief period of oocyst shedding occurs after primary infection [4, 6]. The risk of transmission to infants can be effectively minimized through simple management strategies: daily removal of feces, indoor confinement, feeding of cooked or commercial diets, and avoidance of contact between infants and litter boxes [23, 16, 13]. Veterinary professionals play a critical role in educating pet owners about these measures and in diagnosing and treating feline toxoplasmosis when it occurs [9, 25]. Ongoing research into vaccine development and improved diagnostics may further reduce zoonotic risk in the future [28, 29].

References

[1] Dubey J, Cerqueira-Cézar CK, Murata F, et al. All about toxoplasmosis in cats: the last decade. Vet Parasitol. 2020. URL: https://www.semanticscholar.org/paper/f0acbbba7cd9f8c048d5d0764bbf9a13fc7c158b

[2] Fux B, Covre K, Lopes R, et al. Seroprevalence of Toxoplasmosis in Cats in Espirito Santo State, Brazil. Curr Dev Nutr. 2020. URL: https://www.semanticscholar.org/paper/c8a06a7c2da069a70425a4ee3b10947240fb5aca

[3] Munhoz A, Hage SB, Cruz R, et al. Toxoplasmosis in cats in northeastern Brazil: Frequency, associated factors and coinfection with Neospora caninum, feline immunodeficiency virus and feline leukemia virus. Vet Parasitol Reg Stud Reports. 2017. URL: https://www.semanticscholar.org/paper/7c8a2fdd2e9561c2569bc4e98397bbe347e630a2

[4] Dubey J, Frenkel JK. Cyst-induced toxoplasmosis in cats. J Protozool. 1972. URL: https://www.semanticscholar.org/paper/12d02c2160648955e5516f3c6df5f8ca6fc8d0c5

[5] Crouch EEV, Mittel L, Southard T, et al. Littermate cats rescued from a shelter succumbed to acute, primary toxoplasmosis associated with TOXO DB genotype #4, generally circulating in wildlife. Parasitol Int. 2019. URL: https://www.semanticscholar.org/paper/d461f809816133d61ed266a5eae6e08c1a3dec5c

[6] Dubey J, Thulliez P. Serologic diagnosis of toxoplasmosis in cats fed Toxoplasma gondii tissue cysts. J Am Vet Med Assoc. 1989. URL: https://www.semanticscholar.org/paper/ee22536cb0d4e9d5bd35bdcff522943c207f2843

[7] Dubey JP, Hoover E, Walls K. Effect of age and sex on the acquisition of immunity to toxoplasmosis in cats. J Protozool. 1977. URL: https://www.semanticscholar.org/paper/23dc34fe496f694a558cf945c5ed25693529c1dd

[8] Dubey J. Toxoplasmosis in cats. 1986. URL: https://www.semanticscholar.org/paper/2d40c71cd859696150a18a7a02da5c18e19cb9f6

[9] Calero-Bernal R, Gennari S. Clinical Toxoplasmosis in Dogs and Cats: An Update. Front Vet Sci. 2019. URL: https://www.semanticscholar.org/paper/85289202e785e3bc73f8f5115e9316d859714c0c

[10] Dubey J, Carpenter J. Histologically confirmed clinical toxoplasmosis in cats: 100 cases (1952-1990). J Am Vet Med Assoc. 1993. URL: https://www.semanticscholar.org/paper/d52209abc2a6337a4c9d08f712a537010200385e

[11] Awad R, Barakat A. Serological Diagnosis of Toxoplasmosis in Household Cats in Egypt. Egypt J Vet Sci. 2019. URL: https://www.semanticscholar.org/paper/6ca05ce895e69ecbeddb30d4dfce97e71c204e52

[12] Majid A, Ahmad N, Haleem S, et al. Detection of toxoplasmosis in pets and stray cats through molecular and serological techniques in Khyber Pakhtunkhwa, Pakistan. BMC Vet Res. 2021. URL: https://www.semanticscholar.org/paper/8d881c294db66470f8cb1039711b82f9beddee6c

[13] Kokkinaki KG, Saridomichelakis M, Mylonakis M, et al. Seroprevalence of and Risk Factors for Toxoplasma gondii Infection in Cats from Greece. Animals. 2023. URL: https://www.semanticscholar.org/paper/2bbbd583a9ac38d15c1b6f98ccf07981157adf83

[14] Inpankaew T, Sattasathuchana P, Kengradomkij C, et al. Prevalence of toxoplasmosis in semi-domesticated and pet cats within and around Bangkok, Thailand. BMC Vet Res. 2021. URL: https://www.semanticscholar.org/paper/9d019b6566281c83eacd73785646da54fbe4f464

[15] Galván-Ramírez ML, Charles-Niño C, Pedroza-Roldán C, et al. Prevalence of Toxoplasma gondii Measured by Western Blot, ELISA and DNA Analysis, by PCR, in Cats of Western Mexico. Pathogens. 2022. URL: https://www.semanticscholar.org/paper/4555ef585cbccbbf4dc7f579d6a99ed0fc120ceb *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[16] Karakavuk M, Can H, Selim N, et al. Investigation of the role of stray cats for transmission of toxoplasmosis to humans and animals living in İzmir, Turkey. J Infect Dev Ctries. 2021. URL: https://www.semanticscholar.org/paper/d4034b4469c570f968226bd0f2428a8841127668

[17] Zakaria R, Ardiansyah S. Potential Analysis Of Toxoplasmosis Distribution In Wild Cats (Felis silvestris) In Some Markets Of Sidoarjo District Through Microscopic Identification Of Toxoplasma gondii. Medicra. 2020. URL: https://www.semanticscholar.org/paper/82acd479c09d814fba86964b3561af044fa1539a

[18] Selyemová D, Antolová D, Mangová B, et al. Cats as a sentinel species for human infectious diseases – toxoplasmosis, trichinellosis, and COVID-19. Curr Res Parasitol Vector-Borne Dis. 2024. URL: https://www.semanticscholar.org/paper/ce0b02c41d9424f9078cf916d5152566094d337a

[19] Vainisi SJ, Campbell LH. Ocular toxoplasmosis in cats. 1969. URL: https://www.semanticscholar.org/paper/249b39e2a160380e0392f576ba6c852d4525e72d

[20] Cucos C, Ionascu I, Mocanu J, et al. Neurological and ocular form of toxoplasmosis in cats. 2015. URL: https://www.semanticscholar.org/paper/aa122640585a7963211031f376cc4dfc5aad4bb2

[21] Dubey J, Mattix M, Lipscomb T. Lesions of Neonatally Induced Toxoplasmosis in Cats. Vet Pathol Suppl. 1996. URL: https://www.semanticscholar.org/paper/1254e6ad6e3a8af547409537637842df2c9baaf3

[22] Hasan MF, Harun A, Hossain D, et al. Toxoplasmosis in animals and humans: a neglected zoonotic disease in Bangladesh. J Parasit Dis. 2024. URL: https://www.semanticscholar.org/paper/da821e8fdfc168c67e0410f9698f8797db223dfc

[23] Frenkel JK. Toxoplasmosis in cats: diagnosis, treatment and prevention. Comp Immunol Microbiol Infect Dis. 1978. URL: https://www.semanticscholar.org/paper/83342586a02084c5abca00f2f74a7c8eaed91493

[24] Vinogradov LI. Diagnosis of toxoplasmosis in cats. 1980. URL: https://www.semanticscholar.org/paper/547f904162fe1e9133e7b8fbdd7c56c7fd520f18

[25] Sabukunze S, Gu H, Zhao L, et al. Comparison of the performance of SAG2, GRA6, and GRA7 for serological diagnosis of Toxoplasma gondii infection in cats. Front Vet Sci. 2024. URL: https://www.semanticscholar.org/paper/9f5d168c43119aed8d92f0b3115eb05d8db3dc99

[26] Davidson MG, Lappin M, Rottman JR, et al. Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats. Antimicrob Agents Chemother. 1996. URL: https://www.semanticscholar.org/paper/3c33146daf33215dac6e658719c1d07bb266fdf7

[27] Girling S, Pizzi R, Naylor A, et al. Use of Clindamycin in Pallas' Cats (Otocolobus manul) to Reduce Juvenile Toxoplasmosis-Associated Mortality Rates. J Zoo Wildl Med. 2020. URL: https://www.semanticscholar.org/paper/4feb70d4897b80c8cd1cfacfe59755a6bcd4c598

[28] Shen Y, Zheng B, Sun H, et al. A live attenuated RHΔompdcΔuprt mutant of Toxoplasma gondii induces strong protective immunity against toxoplasmosis in mice and cats. Infect Dis Poverty. 2023. URL: https://www.semanticscholar.org/paper/2c0eccd9ce92a1acbb4617baa6621f2d56e59c5e

[29] Zafar Z, Ali N, Baleanu D. Dynamics and numerical investigations of a fractional-order model of toxoplasmosis in the population of human and cats. 2021. URL: https://www.semanticscholar.org/paper/db91c7fb65e1a1d56be21460221b7855e2809a5c

[30] Ahmad N, Ahmed H, Irum S, et al. Seroprevalence of IgG and IgM antibodies and associated risk factors for toxoplasmosis in cats and dogs from sub-tropical arid parts of Pakistan. Trop Biomed. 2014. URL: https://www.semanticscholar.org/paper/da6e18e25d3ce94af78a72a188b4814bde5a4bf6

[31] Al-Kappany Y, Rajendran C, Ferreira LR, et al. High Prevalence of Toxoplasmosis in Cats from Egypt: Isolation of Viable Toxoplasma gondii, Tissue Distribution, and Isolate Designation. J Parasitol. 2010. URL: https://www.semanticscholar.org/paper/eb0cb3755cb9a332123f4cff955b60832811f357

[32] Shahzad A, Khan MS, Ashraf K, et al. Sero-epidemiological and haematological studies on toxoplasmosis in cats, dogs and their owners in Lahore, Pakistan. 2006. URL: https://www.semanticscholar.org/paper/7d0dfdee60bdf59fcc72a83a2c3ef69c3c975815

[33] Germano PM, Melo H, Bianchin I, et al. Toxoplasmosis in cats and dogs. 1980. URL: https://www.semanticscholar.org/paper/28ba5dd1a8560109667f0cde4939e26be92466a8

[34] Bastan I. Clinical and some laboratory findings in cats with Toxoplasmosis. 2018. URL: https://www.semanticscholar.org/paper/22a23aba5dc5ed1ccad8996586a2a1622e64a857

[35] Brennan A, Donahoe S, Beatty J, et al. Comparison of genotypes of Toxoplasma gondii in domestic cats from Australia with latent infection or clinical toxoplasmosis. Vet Parasitol. 2016. URL: https://www.semanticscholar.org/paper/a080aff8dac0932d82ef96c92dffa298fde93e5f